Neutropaenia in early rheumatoid arthritis: frequency, predicting factors, natural history and outcome

about

Neutropaenia in early rheumatoid arthritis: frequency, predicting factors, natural history and outcome

Item

http://www.wikidata.org/entity/Q58580863

description

im Januar 2018 veröffentlichter wissenschaftlicher Artikel

@de

scientific article published on 08 October 2018

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

Neutropaenia in early rheumato ...... s, natural history and outcome

@en

Neutropaenia in early rheumato ...... s, natural history and outcome

@nl

type

Item

label

Neutropaenia in early rheumato ...... s, natural history and outcome

@en

Neutropaenia in early rheumato ...... s, natural history and outcome

@nl

prefLabel

Neutropaenia in early rheumato ...... s, natural history and outcome

@en

Neutropaenia in early rheumato ...... s, natural history and outcome

@nl

P1476

Neutropaenia in early rheumato ...... s, natural history and outcome

@en

P2093

Ashley Gilmour

http://www.w3.org/2001/XMLSchema#string

Caron Paterson

http://www.w3.org/2001/XMLSchema#string

Duncan Porter

http://www.w3.org/2001/XMLSchema#string

Iain B McInnes

http://www.w3.org/2001/XMLSchema#string

Mohammad H Derakhshan

http://www.w3.org/2001/XMLSchema#string

Stefan Siebert

http://www.w3.org/2001/XMLSchema#string

P2860

Cellular softening mediates leukocyte demargination and trafficking, thereby increasing clinical blood counts.

Rituximab associated late-onset neutropenia-a rheumatology case series and review of the literature.

Late-onset neutropenia after treatment with rituximab for rheumatoid arthritis and other autoimmune diseases: data from the AutoImmunity and Rituximab registry.

Cigarette smoking and irinotecan treatment: pharmacokinetic interaction and effects on neutropenia.

Adverse reactions to disease-modifying anti-rheumatic drugs in clinical practice.

Baseline laboratory test abnormalities are common in early arthritis but rarely contraindicate methotrexate: study of three cohorts (ESPOIR, VErA, and Brittany).

Clinical characteristics and risk factors for low dose methotrexate toxicity: a cohort of 28 patients.

Sulphasalazine in rheumatoid arthritis: haematological problems and changes in haematological indices associated with therapy.

Leucopenia during sulphasalazine treatment for rheumatoid arthritis

2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis.

P304

e000739

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/RMDOPEN-2018-000739

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

George E Fragoulis

P577

2018-10-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30402267

http://www.w3.org/2001/XMLSchema#string

P932

6203094

http://www.w3.org/2001/XMLSchema#string